Katherine Wajda, MD
-
Specialty: Pulmonary and Critical Care Medicine
View Expertise -
Primary Location: 11100 Euclid Ave (0 mi.)
Other Locations - Languages Spoken: English
Office Locations
UH Cleveland Medical Center Bolwell (0 mi.)
11100 Euclid Ave
Bolwell 6th Floor
Cleveland, OH 44106
216-844-8500
UH Rainbow Babies & Children's Hospital (0 mi.)
11100 Euclid Ave
Ste 604
Cleveland, OH 44106
216-844-3267
UH Minoff Health Center (7 mi.)
3909 Orange Pl
Ste 3100
Beachwood, OH 44122
216-844-3201
Biography: Katherine Wajda, MD
Expertise
Certifications & Memberships
- Critical Care Medicine - American Board of Internal Medicine
- Pulmonary Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Pulmonary/Critical Care
Pulmonary/Critical Care - UH Cleveland Medical Center (2020 - 2023)
Residency | Internal Medicine/Pediatrics
Internal Medicine/Pediatrics - Metrohealth Medical Center (2016 - 2020)
Medical Education
Wright State University Boonshoft School Of Medicine (2016)
Undergraduate
University Of Dayton (2012)
About
Katherine Bruening Wajda, MD, is a pulmonary and critical care physician at University Hospitals specializing in asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Dr. Wajda is board certified in pulmonary disease, critical care medicine and internal medicine.
Dr. Wajda earned her medical degree from Wright State University Boonshoft School of Medicine (Dayton, Ohio) in 2016. She began her doctoral training with a residency in internal medicine and pediatrics at Metrohealth Medical Center (Cleveland, Ohio) completed in 2020. She then completed a pulmonary and critical care fellowship at University Hospitals Cleveland Medical Center, serving as Academic Chief Fellow from 2022 to 2023.
Dr. Wajda is the recipient of a number of honors and awards recognizing her work in resident teaching and internal medicine-pediatric research. Along with these accomplishments, she has published several peer-reviewed presentations and journal articles.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Katherine Wajda did not disclose any Outside Relationships with Industry.